webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate

  CAS No.:   Cat No.: BADC-00451   Purity: 98% 4.5  

2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is a biomedical compound. Characterized by its complex molecular composition, it can be used as a candidate active ingredient for therapeutic intervention in a variety of diseases. Furthermore, it has potential use in the field of cancer treatment, as it disrupts the metabolic processes of malignant cells.

2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H20N2O9
Molecular Weight
384.34
Shipping
Room temperature
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Mal-PEG3-NHS
Appearance
Soild powder
Shipping
Room temperature
Storage
-20°C

2,5-Dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate, commonly used due to its versatile chemical properties, plays a significant role in the pharmaceutical industry. One of its key applications is as a coupling agent in the synthesis of peptide chains. Its chemical structure allows it to facilitate the formation of peptide bonds between amino acids efficiently, which is essential for creating complex peptide sequences required in modern drug development. This compound’s ability to activate carboxyl groups enables the formation of amide bonds with amines, thereby streamlining the synthetic routes for producing therapeutic peptides. This efficient peptide bonding significantly impacts the development and manufacturing of peptide-based medications.

Another critical application of 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is in bioconjugation techniques. Bioconjugation involves the covalent binding of biomolecules to other molecules, such as adding drugs to antibodies to form antibody-drug conjugates (ADCs). This compound can facilitate the formation of stable linkages between the drug and the antibody, ensuring that the ADCs deliver the therapeutic agents specifically to the target cells, minimizing off-target effects and enhancing therapeutic efficacy. ADCs represent a significant advancement in targeted cancer therapies, providing the ability to deliver cytotoxic drugs directly to cancerous tissues while sparing healthy cells.

In the realm of material sciences, this compound serves as a crosslinking agent in the development of hydrogels and polymer networks. Hydrogels, which are networks of polymer chains that can hold a large amount of water, are used extensively in biomedical applications such as tissue engineering, wound dressings, and drug delivery systems. The ability of 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate to crosslink polymer chains enhances the mechanical properties and stability of hydrogels, making them more suitable for clinical applications. Its role ensures that these hydrogels can meet the stringent demands of biomedical use, including biocompatibility, biodegradability, and mechanical strength.

Lastly, in organic synthesis, 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is utilized as an esterification agent. It is particularly effective in the synthesis of esters from carboxylic acids and alcohols. This process is fundamental in the production of a wide range of organic compounds, including flavors, fragrances, and pharmaceuticals. The efficiency and mild reaction conditions offered by this compound make it a valuable tool in chemical laboratories focused on organic synthesis, enabling the production of high-purity esters without the need for excessive purification steps. Its use streamlines the workflow in synthetic organic chemistry, making the production processes more efficient and less resource-intensive.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bis-PEG2-NHS Ester | Ald-PEG4-NHS ester | Ald-Ph-PEG3-acid | Ald-Ph-PEG4-acid | H-D-trans-Hyp-OMe HCl | M4-Nitrodienamine | DBM(C6)-VC-PAB-MMAE | Mal-L-Dap(Boc)-OH | sulfo-LC-SPDP | N-(2-azidoacetyl)glycine DCHA salt | 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate
Send Inquiry
Verification code
Inquiry Basket